OMER Competitors & Alternatives
Compare Omeros Corporation with similar stocks in the same industry
Biotechnology
OMER
Main Stock$12.56
Tradestie Score
56
Market Cap
$281.75M
P/E Ratio
10.4
Revenue Growth
0.1%
Analyst Upside
+162.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.36
|
$879.90M | 5.2 | 51 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$8.98
|
$871.90M | - | 52 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$8.94
|
$868.46M | - | 53 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$5.78
|
$867.49M | - | 54 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$18.94
|
$864.42M | - | 56 | Compare |
|
CRMD
CorMedix Inc.
|
$7.55
|
$862.55M | 3.5 | 49 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$34.98
|
$847.12M | - | 51 | Compare |
|
XNCR
Xencor, Inc.
|
$19.40
|
$843.75M | - | 53 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$28.19
|
$841.74M | - | 57 | Compare |
|
ANL
ANL
|
$12.99
|
$837.17M | - | 53 | Compare |
More OMER Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry